Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: The HEIRS study

Thyroid

Volumn 18, Issue 8, 2008, Pages 831-838

  Barton, James C ^a   Leiendecker Foster, Catherine ^b   Reboussin, David M ^c   Adams, Paul C ^d   Acton, Ronald T ^e   Eckfeldt, John H ^b  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; HYPOTHYROIDISM; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREVALENCE; THYROTROPIN; THYROXINE;

EID: 50649106211     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0091     Document Type: Article

References (47)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr., Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK 1996 A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408.
2. Beutler E, Felitti V, Gelbart T, Ho N 2000 The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 133:329-337.
3. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P 2005 Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769-1778.
4. Barton JC, Wiener HW, Acton RT, Go RC 2005 HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 34:38-47.
5. Bezwoda WR, Bothwell TH, Van Der Walt LA, Kronheim S, Pimstone BL 1977 An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis. Clin Endocrinol (Oxf) 6:377-385.
6. Edwards CQ, Kelly TM, Ellwein G, Kushner JP 1983 Thyroid disease in hemochromatosis. Increased incidence in homozygous men. Arch Intern Med 143:1890-1893.
7. Varela C, Hurtado A, Boixeda D, Garcia RR, Calle H, Zurita P, Sancho J 1983 [Gonadal and pituitary function in idiopathic hemochromatosis]. Med Clin (Barc) 81:606-609.
8. Barton JC, Barton NH, Alford TJ 1997 Diagnosis of hemochromatosis probands in a community hospital. Am J Med 103:498-503.
9. Murphy MS, Walsh CH 2004 Thyroid function in haemochromatosis. Ir J Med Sci 173:27-29.
10. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, Cappuccio JD 1998 Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 129:954-961.
11. Asberg A, Hveem K, Kruger O, Bjerve KS 2002 Persons with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol 37:719-724.
12. Delatycki MB, Allen KJ, Nisselle AE, Collins V, Metcalfe S, du SD, Halliday J, Aitken MA, Macciocca I, Hill V, Wakefield A, Ritchie A, Gason AA, Nicoll AJ, Powell LW, Williamson R 2005 Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 366:314-316.
13. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, Reboussin DM, McLaren GD, Sholinsky P, Walker AP, Gordeuk VR, Leiendecker-Foster C, Dawkins FW, Eckfeldt JH, Mellen BG, Speechley M, Thomson E 2003 Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 325:53-62.
14. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL 2005 Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 9:231-241.
15. SAS v. 9.02004 SAS Institute, Cary, NC.
16. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
17. Jensen E, Hyltoft PP, Blaabjerg O, Hansen PS, Brix TH, Kyvik KO, Hegedus L 2004 Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults: the importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med 42:824-832.
18. Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J 2005 New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 51:1480-1486.
19. Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U, Meng W 2005 Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 15:279-285.
20. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE 2007 National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 92:4236-4240.
21. Waalen J, Beutler E 2005 Beware of multiple comparisons: a study of symptoms associated with mutations of the HFE hemochromatosis gene. Clin Chim Acta 361:128-134.
22. Bergeron C, Kovacs K 1978 Pituitary siderosis: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 93:295-309.
23. Walsh CH 2000 Non-diabetic endocrinopathy in hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathogenesis, diagnosis and treatment. Cambridge University Press, Cambridge, p. 278.
24. Stocks AE, Martin FI 1968 Pituitary function in haemochromatosis. Am J Med 45:839-845.
25. Stocks AE, Powell LW 1972 Pituitary function in idiopathic haemochromatosis and cirrhosis of the liver. Lancet 2:298-300.
26. Siemons LJ, Mahler CH 1987 Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab 65:585-587.
27. Gama R, Smith MJ, Wright J, Marks V 1995 Hypopituitarism in primary haemochromatosis: recovery after iron depletion. Postgrad Med J 71:297-298.
28. Wilkinson H 1996 Haemochromatosis associated with arthritis and hypopituitarism. Ann Clin Biochem 33(Pt 2):171-173.
29. Hudec M, Grigerova M, Walsh CH 2008 Secondary hypothyroidism in hereditary hemochromatosis: recovery after iron depletion. Thyroid 18:255-257.
30. Sheldon J 1935 Haemochromatosis. Oxford University Press, London, pp 128-152.
31. MacDonald RA, Mallory GK 1960 Hemochromatosis and hemosiderosis. Study of 211 autopsied cases. Arch Intern Med 105:686-700.
32. Olynyk JK, Luxon BA, Britton RS, Bacon BR 1998 Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements. Am J Gastroenterol 93:346-350.
33. Beutler E, Felitti V, Ho NJ, Gelbart T 2002 Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 107:145-149.
34. Hashimoto T, Matsubara F 1989 Changes in the tumor marker concentration in female patients with hyper-, eu-, and hypothyroidism. Endocrinol Jpn 36:873-879.
35. Deshpande UR, Nadkarni GD 1992 Relation between thyroid status and ferritin metabolism in rats. Thyroidology 4:93-97.
36. Barton JC, Acton RT 2002 HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet 3:9.
37. Tandon N, Zhang L, Weetman AP 1991 HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf ) 34:383-386.
38. Levin L, Ban Y, Concepcion E, Davies TF, Greenberg DA, Tomer Y 2004 Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum Immunol 65:640-647.
39. Ratanachaiyavong S, McGregor AM 1994 HLA-DPB1 polymorphisms on the MHC-extended haplotypes of families of patients with Graves' disease: two distinct HLA-DR17 haplotypes. Eur J Clin Invest 24:309-315.
40. Williams RS 1959 Increased thyroid function in haemochromatosis. Br Med J 1:1078-1080.
41. Barton JC, Bertoli LF, Acton RT 2003 Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. Blood Cells Mol Dis 31:102-111.
42. Mirza G, Williams RR, Mohammed S, Clark R, Newbury-Ecob R, Baldinger S, Flinter F, Ragoussis J 2004 Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Eur J Hum Genet 12:718-728.
43. Naylor SL, Chin WW, Goodman HM, Lalley PA, Grzeschik KH, Sakaguchi AY 1983 Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse. Somatic Cell Genet 9:757-770.
44. Dracopoli NC, Rettig WJ, Whitfield GK, Darlington GJ, Spengler BA, Biedler JL, Old LJ, Kourides IA 1986 Assignment of the gene for the beta subunit of thyroid-stimulating hormone to the short arm of human chromosome 1. Proc Natl Acad Sci USA 83:1822-1826.
45. Johns Hopkins University 2007 *118850. Chorionic gonadotrophin, alpha chain; CGA. Online Mendelian Inheritance in Man (OMIM). http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=118850.
46. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA 1996 Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 245:139-200.
47. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E 2002 Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clin Proc 77:522-530.